ArticleFrontiers in public health2025
Burdens of idiopathic developmental intellectual disability attributable to lead exposure from 1990 to 2021 and projection to 2035 in China: findings from the 2021 global burden of disease study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Burdens of Idiopathic Developmental Intellectual Disability Attributable to Lead Exposure from 1990 to 2023 and a Projection to 2050 in the USA: Findings from the Global Burden of Disease Study 2023.Healthcare (Basel, Switzerland) · 2026Article
- Article
- Global and China burden and trend prediction of thyroid cancer attributed to high BMI from 1990 to 2021.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze the burden and trend of idiopathic developmental intellectual disability (IDII) attributed to lead (Pb) exposure in China from 1990 to 2021 and to predict the trend from 2022 to 2035. Method: We used the Global Burden of Disease Study (GBD) 2021 data to estimate disability-adjusted life years (DALYs) and age-standardized DALY rate (ASDR) of IDII attributable to Pb exposure. The annual average percentage change (AAPCs) was estimated to evaluate the changing trend of IDII ASDR attributable to Pb exposure from 1990 to 2021. The age-period-cohort (APC) and Bayesian age-period-cohort (BAPC) was used to assess and predict changes in the DALYs of IDII attributable to Pb exposure. Result: From 1990 to 2021, the number of DALYs and rate of the total population, males and females in China showed a fluctuating and decreasing trend. The APC showed that the age deviation had an upward trend and then decreased, the period deviation showed an ' Conclusion: From 1990 to 2035, the burden of IDII attributed to Pb exposure in China showed a downward trend. But the DALYs and ASDR in females will be higher than that in males in 2035. It is essential to prioritize intervention, prevention, and control measures for females.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.